Abstract
Cerebral malaria (CM) is a major life-threatening disease caused by Plasmodium falciparum infection in humans. The complex pathogenic mechanisms underlying the fatal neurological complications of the disease are still not completely elucidated. The autopsy studies in fatal cases of human CM and advances in knowledge from various animal models have offered insight into the precise mechanism of the disease. The parasite sequestration in the brain microvascular endothelial cells and dysregulated host immune system together determine the pathophysiology of CM. Despite optimal treatment with antimalarials, 25% of the patients suffer from post-treatment neurological and cognitive deficits. In this review, we have discussed the components of the pathogenic mechanisms of CM and the current scenario of treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armah H, Dodoo AK, Wiredu EK, Stiles JK, Adjei AA, Gyasi RK et al (2005a) High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol 99:629–647
Armah H, Wired EK, Dodoo AK, Adjei AA, Tettey Y, Gyasi R (2005b) Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Int J Environ Res Public Health 2:123–131
Baruch DI (1999) Adhesive receptors on malaria-parasitized red cells. Best Pract Res Clin Haematol 12:747–761
Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM et al (2007) Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 119:e360–e366
Brown H, Turner G, Rogerson S, Tembo M, Mwenechanya J, Molyneux M et al (1999) Cytokine expression in the brain in human cerebral malaria. J Infect Dis 180(5):1742–1746
Casals-Pascual C, Idro R, Gicheru N, Gwer S, Kitsao B, Gitau E et al (2008) High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci U S A 105(7):2634–2639
Charunwatthana P, Abul Faiz M, Ruangveerayut R et al (2009) N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit Care Med 37:516–522
Chattopadhyay R, Taneja T, Chakrabarti K, Pillai CR, Chitnis CE (2004) Molecular analysis of the cytoadherence phenotype of a Plasmodium falciparum field isolate that binds intercellular adhesion molecule-1. Mol Biochem Parasitol 133(2):255–265
Combes V, El-Assaad F, Faille D, Jambou R, Hunt NH, Grau GE (2010) Microvesiculation and cell interactions at the brain-endothelial interface in cerebral malaria pathogenesis. Prog Neurobiol 91:140–150
Crabb BS, Cooke BM, Reeder JC, Waller RF, Caruana SR, Davern KM et al (1997) Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress. Cell 89:287–296
Craig A, Scherf A (2001) Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol Biochem Parasitol 115:129–143
Dalko E, Tchitchek N, Pays L, Herbert F, Cazenave PA, Ravindran B, Sharma S, Nataf S, Das B, Pied S (2016) Erythropoietin levels increase during cerebral malaria and correlate with heme, Interleukin-10 and tumor necrosis factor-alpha in India. PLoS One 11:e0158420
Das BK, Mishra S, Padhi PK, Manish R, Tripathy R, Sahoo PK et al (2003) Pentoxifylline adjunct improves prognosis of human cerebral malaria in adults. Trop Med Int Health 8:680–684
David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD (1983) Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoaderence of infected erythrocytes. Proc Natl Acad Sci U S A 80(16):5075–5079
Deininger MH, Kremsner PG, Meyermann R, Schluesener HJ (2000) Differential cellular accumulation of transforming growth factor-beta1, −beta2, and -beta3 in brains of patients who died with cerebral malaria. J Infect Dis 181(6):2111–2115
de Souza JB, Riley EM (2002) Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect 4(3):291–300
Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D et al (2011) The neuropathology of fatal cerebral malaria in Malawian children. Am J Pathol 178:2146–2158
Emuchay CI, Usanga EA (1997) Increased platelet factor 3 activity in Plasmodium falciparum malaria. East Afr Med J 74:527–529
Gazzinelli RT, Denkers EY (2006) Protozoan encounters with toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 6:895–906
Glushakova S, Busse BL, Garten M, Beck JR, Fairhurst RM, Goldberg DE, Zimmerberg J (2017) Exploitation of a newly-identified entry pathway into the malaria parasite-infected erythrocyte to inhibit parasite egress. Sci Rep 7:12250. https://doi.org/10.1038/s41598-017-12258-x
Gordeuk V, Thuma P, Brittenham G, McLaren C, Parry D, Backenstose A et al (1992) Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 327(21):1473–1477
Gordeuk VR, Loyevsky M (2002) Antimalarial effect of iron chelators. Adv Exp Med Biol 509:251–272
Griffiths MJ, Ndungu F, Baird KL, Muller DP, Marsh K, Newton CR (2001) Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. Br J Haematol 113(2):486–491
Heddini A, Chen Q, Obiero J, Kai O, Fernandez V, Marsh K et al (2001) Binding of Plasmodium falciparum-infected erythrocytes to soluble platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): frequent recognition by clinical isolates. Am J Trop Med Hyg 65:47–51
Ho M, White NJ (1999) Molecular mechanisms of cytoadherence in malaria. Am J Physiol 276:C1231–C1242
Howard RJ, Handunnetti SM, Hasler T, Gilladoga A, de Aguiar JC, Pasloske BL et al (1990) Surface molecules on Plasmodium falciparum-infected erythrocytes involved in adherence. Am J Trop Med Hyg 43:15–29
Hsieh F-L, Turner L, Bolla JR, Robinson CV, Lavstsen T, Higgins MK (2016) The structural basis for CD36 binding by the malaria parasite. Nat Commun 7:12837
John CC, Kutamba E, Mugarura K, Opoka RO (2010) Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti-Infect Ther 8(9):997–1008
Lell B, Köhler C, Wamola B, Olola CH, Kivaya E, Kokwaro G, Wypij D, Mithwani S, Taylor TE, Kremsner PG, Newton CR (2010) Pentoxifylline as an adjunct therapy in children with cerebral malaria. Malar J 21:368–369
Looareesuwan S, Wilairatana P, Vannaphan S, Wanaratana V, Wenisch C, Aikawa M, Brittenham G, Graninger W, Wernsdorfer WH (1998) Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. Achieves Dis Child 58:348–353
Looareesuwan S, Sjostrom L, Krudsood S, Wilairatana P, Porter RS, Hills F et al (1999) Polyclonal anti-tumor necrosis factor-alpha fab used as an ancillary treatment for severe malaria. Am J Trop Med Hyg 61(1):26–33
Loutan L, Plancherel C, Soulier-lauper M, Pascual M, Subilia L, Chevrolet JC, Unger PF, Grau GE (1992) Serum TNF in patients with severe malaria treated by exchange transfusion. Trop Med Parasitol 43:285–286
Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton C et al (2005) Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clin Infect Dis 40:538–545
Maneerat Y, Pongponratn E, Viriyavejakul P, Punpoowong B, Looareesuwan S, Udomsangpetch R (1999) Cytokines associated with pathology in the brain tissue of fatal malaria. Southeast Asian J Trop Med Public Health 30(4):643–649
Martins YC, Carvalho LJ, Daniel-Ribeiro CT (2009) Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models. Neuroimmunomodulation 16(2):134–145
Miller LH, Ackerman HC, Su XZ, Wellems TE (2013) Malaria biology and disease pathogenesis: insights for new treatments. Nat Med 19:156–167
Mohanty D, Ghosh K, Pathare AV, Karnad D (2002) Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria. Indian J Med Res 115:17–21
Mohanty S, Mishra SK, Patnaik R, Dutt AK, Pradhan S, Das B, Patnaik J, Mohanty AK, Lee SJ, Dondorp AM (2011) Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial. Clin Infect Dis 53:349–355
Namutangula B, Ndeezi G, Byarugaba JS, Tumwine JK (2007) Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial. Malar J 24:138
Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B et al (1997a) Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 57(4):389–398
Newbold CI, Craig AG, Kyes S, Berendt AR, Snow RW, Peshu N et al (1997b) PfEMP1, polymorphism and pathogenesis. Ann Trop Med Parasitol 91(5):551–557
Ockenhouse CF, Tegoshi T, Maeno Y, Benjamin C, Ho M, Kan KE et al (1992) Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med 176:1183–1189
Pongponratn E, Turner GD, Day NP, Phu NH, Simpson JA, Stepniewska K et al (2003) An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am J Trop Med Hyg 69:345–359
Ponsford MJ, Medana IM, Prapansilp P, Hien TT, Lee SJ, Dondorp AM et al (2012) Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis 205:663–671
Pouvelle B, Matarazzo V, Jurzynski C, Nemeth J, Ramharter M, Rougon G, Gysin J (2007) Neural cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum-infected erythrocytes capable of aggregation. Infect Immun 75(7):3516–3522
Rampengan TH (1991) Cerebral malaria in children. Comparative study between heparin, dexamethasone and placebo. Paediatr Indones 31:59–66
Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, Olomi R et al (2005) Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. J Am Med Assoc 293:1461–1470
Riddle MS, Jeffery LJ, Sanders JH, Blazes DL (2002) Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis 1:1192–1198
Rogerson SJ, Reeder JC, Al-Yaman F, Brown GV (1994) Sulfated glycoconjugates as disrupters of Plasmodium falciparum erythrocyte rosettes. Am J Trop Med Hyg 51:198–203
Sahu PK, Satpathi S, Behera PK, Mishra SK, Mohanty S, Wassmer SC (2015) Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches. Front Cell Infect Microbiol 5:75
Scott CS, Van Zyl D, Ho E, Ruivo L, Mendelow B, Coetzer TL (2002) Thrombocytopenia in patients with malaria: automated analysis of optical platelet counts and platelet clumps with the cell Dyn CD4000 analyser. Clin Lab Haematol 24:295–302
Sein KK, Maeno Y, Thuc HV, Anh TK, Aikawa M (1993) Differential sequestration of parasitized erythrocytes in the cerebrum and cerebellum in human cerebral malaria. Am J Trop Med Hyg 48:504–511
Seydel KB, Milner DA Jr, Kamiza SB, Molyneux ME, Taylor TE (2006) The distribution and intensity of parasite sequestration in comatose Malawian children. J Infect Dis 194:208–205
Seydel KB, Kampondeni SD, Valim C, Potchen MJ, Milner DA, Muwalo FW et al (2015) Brain swelling and death in children with cerebral malaria. N Engl J Med 372:1126–1137
Springer AL, Smith LM, Mackay DQ, Nelson SO, Smith JD (2004) Functional interdependence of the DBLbeta domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. Mol Biochem Parasitol 137:55–64
Srivastava K, Field DJ, Aggrey A, Yamakuchi M, Morrell CN (2010) Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria. PLoS One 5:e10413. https://doi.org/10.1371/journal.pone.0010413
Taylor TE, Molyneux ME, Wirima JJ, Borgstein A, Goldring JD, Hommel M (1992) Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin Exp Immunol 90(3):357–362
Thuma PE, Mabeza GF, Biemba G, Bhat GJ, McLaren CE, Moyo VM, Zulu S, Khumalo H, Mabeza P, M’Hango A, Parry D, Poltera AA, Brittenham GM, Gordeuk VR (1998) Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans R Soc Trop Med Hygeine 92:214–218
Tongren JE, Yang C, Collins WE, Sullivan JS, Lal AA, Xiao L (2000) Expression of proinflammatory cytokines in four regions of the brain in macaque mulatta (rhesus) monkeys infected with Plasmodium coatneyi. Am J Trop Med Hyg 62(4):530–534
Tse MT, Chakrabarti K, Gray C, Chitnis CE, Craig A (2004) Divergent binding sites on intercellular adhesion molecule-1 (ICAM-1) for variant Plasmodium falciparum isolates. Mol Microbiol 51:1039–1049
Udomsangpetch R, Reinhardt PH, Schollaardt T, Elliott JF, Kubes P, Ho M (1997) Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J Immunol 158(9):4358–4364
Van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, Dolan G et al (1996) The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 174:1091–1097
Warrell DA (1997) Cerebral malaria: clinical features, pathophysiology and treatment. Ann Trop Med Parasitol 91:875–884
Wassmer SC, Taylor TE, Rathod PK, Mishra SK, Mohanty S, Arevalo-Herrera M et al (2015) Investigating the pathogenesis of severe malaria: a multidisciplinary and cross-geographical approach. Am J Trop Med Hyg 93(3 Suppl):42–56
Watt G, Jongsakul K, Ruangvirayuth R (2002) A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. Q J Med 95:285–290
White NJ (1996) The treatment of malaria. N Engl J Med 335(11):800–806
WHO (2015) World Malaria Report, WHO Bulletin
Yipp BG, Hickey MJ, Andonegui G, Murray AG, Looareesuwan S, Kubes P et al (2007) Differential roles of CD36, ICAM-1, and P-selectin in Plasmodium falciparum cytoadherence in vivo. Microcirculation 14:593–602
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dwivedi, H., Tripathi, R. (2018). Cerebral Malaria: Players in the Pathogenic Mechanism and Treatment Strategies. In: Singh, P. (eds) Infectious Diseases and Your Health. Springer, Singapore. https://doi.org/10.1007/978-981-13-1577-0_3
Download citation
DOI: https://doi.org/10.1007/978-981-13-1577-0_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1576-3
Online ISBN: 978-981-13-1577-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)